Skip to content
Recall Observatory FDA recall evidence

Drug product

Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC 43975-253-14) bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ

D-0344-2019

December 20, 2018

Class III

Product summary

Firm
Amerigen Pharmaceuticals Inc.
Event
Event 81858
Status
Terminated
Classification
Class III
Quantity
3552 bottles
Official record key
drug-enforcement:D-0344-2019

Official wording

Reason: Failed Dissolution Specifications

Code information: a) Lot # 18B005 A and b) Lot # 18B005 B, exp 02/2020

Distribution pattern: Product was distributed to 4 wholesalers and 2 retail accounts who may have further distributed the products.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications